Ethyl 3-(2-amino-2-oxoethoxy)pyrido[1,2-a]indole-10-carboxylate, 250mg

Dipropylenglykolmonopropylether, min 98 %, zur Synthese, 5 l, kunststoffverpackung.

4-[2-(4-Fluoro-phenyl)-ethyl]-piperidine hydrochloride, 500mg

2-Amino-4-chloro-6-hydroxy-5-nitropyrimidine, 95.0%, 1g

(2-FLUORO-4,6-DIMETHOXYPHENYL)BORONIC ACID, 95%, 10g

4-Chloro-7-fluoro-2,3-dihydro-1h-indole-2,3-dione, 97%, 250mg

1-(Benzyloxy)-3-nitrobenzene, 95.0%, 5g

2-[(2-Methylpropan-2-yl)oxycarbonyl]-7-oxo-2,6-diazaspiro[3.4]octane-5-carboxylic acid, 98+%, 100mg

(2,4,6-trimethylphenyl)methanol, 97.0%, 5g

2-Bromo-3-chlorothiophene, 95.0%, 1g

N1,N1-DIMETHYL-2-(TRIFLUOROMETHYL)BENZENE-1,4-DIAMINE, 95%, 5g

19-Bromo-2,5,8,11,14,17-hexaoxanonadecane, 95%, 1g

TERT-BUTYL (1-(2-AMINOETHYL)CYCLOPROPYL)CARBAMATE, 95.0%, 1g